Technology
Health
Biotechnology

DiaMedica Therapeutics Inc. Common Stock

$3.95
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.61 (18.26%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell DMAC and other stocks, options, ETFs, and crypto commission-free!

About

DiaMedica Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It offers DM199 product which focuses on acute ischemic stroke (AIS), and chronic kidney disease (CKD). Read More The company was founded by Wayne Lautt on January 21, 2000 and is headquartered in Minneapolis, MN.

Employees
7
Headquarters
Minneapolis, Minnesota
Founded
2000
Market Cap
26.18M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
26.19K
High Today
$3.95
Low Today
$3.35
Open Price
$3.36
Volume
130.56K
52 Week High
$13.77
52 Week Low
$2.46

Collections

Technology
Health
Biotechnology
Therapy
Medical
Biopharmaceutical
Pharmaceutical
2018 IPO

Earnings

Q4 2018
Estimated
Actual
Available Mar 19, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.